RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Isofol Medical AB (publ) Stock

Isofol Medical AB (publ) ROA 2024

Isofol Medical AB (publ) ROA

-0.26

Ticker

ISOFOL.ST

ISIN

SE0009581051

WKN

A2DPV6

In 2024, Isofol Medical AB (publ)'s return on assets (ROA) was -0.26, a -65.37% increase from the -0.76 ROA in the previous year.

Isofol Medical AB (publ) Aktienanalyse

What does Isofol Medical AB (publ) do?

Isofol Medical AB (publ) is a Swedish company that was founded in 2006 and is listed on the Nasdaq Stockholm exchange. The company focuses on the development of medical solutions for a wide range of diseases, with a particular emphasis on cancer treatment. Isofol's main product is Modufolin, a proprietary technology that is an advancement of the well-known drug Folic Acid, commonly used in cancer therapy. Modufolin has a longer duration in the body, making it more effective in inhibiting tumor cell growth. Isofol also has a diagnostic division that specializes in developing tests for detecting Vitamin B12 levels in the body, which are crucial for identifying diseases such as dementia and anemia. Isofol Medical AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Isofol Medical AB (publ)'s Return on Assets (ROA)

Isofol Medical AB (publ)'s Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Isofol Medical AB (publ)'s ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Isofol Medical AB (publ)'s ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Isofol Medical AB (publ)’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Isofol Medical AB (publ) stock

What is the Return on Assets (ROA) of Isofol Medical AB (publ) this year?

The Return on Assets (ROA) of Isofol Medical AB (publ) is -0.26 undefined this year.

What was the ROA of Isofol Medical AB (publ) compared to the previous year?

The ROA of Isofol Medical AB (publ) has increased by -65.37% compared to the previous year.

What consequences do high ROA have for investors of Isofol Medical AB (publ)?

A high ROA is advantageous for investors of Isofol Medical AB (publ), as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Isofol Medical AB (publ)?

A low ROA can be unfavorable for investors of Isofol Medical AB (publ) as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Isofol Medical AB (publ) affect the company?

An increase in ROA of Isofol Medical AB (publ) can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Isofol Medical AB (publ) impact the company?

A reduction in the ROA of Isofol Medical AB (publ) can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Isofol Medical AB (publ)?

Some factors that can influence the ROA of Isofol Medical AB (publ) include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Isofol Medical AB (publ) important for investors?

The ROA of Isofol Medical AB (publ) is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Isofol Medical AB (publ) take to improve ROA?

To improve ROA, Isofol Medical AB (publ) can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Isofol Medical AB (publ) pay?

Over the past 12 months, Isofol Medical AB (publ) paid a dividend of 0.76 SEK . This corresponds to a dividend yield of about 33.57 %. For the coming 12 months, Isofol Medical AB (publ) is expected to pay a dividend of 0.76 SEK.

What is the dividend yield of Isofol Medical AB (publ)?

The current dividend yield of Isofol Medical AB (publ) is 33.57 %.

When does Isofol Medical AB (publ) pay dividends?

Isofol Medical AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Isofol Medical AB (publ)?

Isofol Medical AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Isofol Medical AB (publ)?

For the upcoming 12 months, dividends amounting to 0.76 SEK are expected. This corresponds to a dividend yield of 33.57 %.

In which sector is Isofol Medical AB (publ) located?

Isofol Medical AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Isofol Medical AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Isofol Medical AB (publ) from 2/20/2023 amounting to 0.755 SEK, you needed to have the stock in your portfolio before the ex-date on 2/14/2023.

When did Isofol Medical AB (publ) pay the last dividend?

The last dividend was paid out on 2/20/2023.

What was the dividend of Isofol Medical AB (publ) in the year 2023?

In the year 2023, Isofol Medical AB (publ) distributed 0 SEK as dividends.

In which currency does Isofol Medical AB (publ) pay out the dividend?

The dividends of Isofol Medical AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Isofol Medical AB (publ)

Our stock analysis for Isofol Medical AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Isofol Medical AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.